All lobbying filings
LMH Strategic Solutions
LMH Strategic Solutions filed a Q3 report for Neuropace, Inc. on October 20, 2025, reporting $50,000 in lobbying income.
Lobbying for Neuropace, Inc. · Develops & manufactures implantable devices for the treatment of neurological disorders.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
4
Lobbying activity
1
Proposed changes to the FY 2026 Medicare Hospital Inpatient Prospective Payment System and Long-Term Care Hospitals proposed rule.